...
首页> 外文期刊>Oncology: International Journal of Cancer Research and Treatment >Prognostic value of metastatic nodal volume and lymph node ratio in patients with cervical lymph node metastases from an unknown primary tumor
【24h】

Prognostic value of metastatic nodal volume and lymph node ratio in patients with cervical lymph node metastases from an unknown primary tumor

机译:转移性淋巴结体积和淋巴结比率对未知原发性宫颈淋巴结转移患者的预后价值

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Objective: The presence of metastatic cervical lymph nodes (MCNs) is an unfavorable prognostic factor in head and neck cancer. The total volume of MCNs (MNV) and the lymph node ratio (LNR) may be superior to conventional nodal staging in cervical metastasis from an unknown primary tumor (CUP). We evaluated the prognostic value of MNV and LNR in CUP patients. Methods: Thirty-nine patients with CUP who underwent surgery plus postoperative radiotherapy were reviewed. MNV was measured by preoperative computed tomography and LNR was determined using neck dissection samples. The association of clinicopathologic factors, MNV, and LNR with disease-free survival (DFS) and overall survival (OS) was analyzed. Results: Five-year DFS and OS were 68.4 and 70.8%, respectively, for a median follow-up of 49 months. In multivariate analysis, MNV (>30 ml) was an independent prognostic factor for both DFS and OS (p = 0.004 and p < 0.001, respectively). LNR (>0.14) was identified as an independent predictive factor for DFS (p = 0.041). Conclusion: MNV and LNR are independent prognostic factors in patients with CUP and could facilitate the identification of high-risk patients requiring intensive treatment and surveillance.
机译:目的:转移性颈淋巴结(MCNs)的存在是头颈癌的不利预后因素。 MCN的总体积(MNV)和淋巴结比率(LNR)在因未知原发性肿瘤(CUP)引起的宫颈转移中可能优于常规的淋巴结分期。我们评估了MNV和LNR在CUP患者中的预后价值。方法:对39例行手术加术后放疗的CUP患者进行回顾。通过术前计算机断层扫描测量MNV,并使用颈部解剖样本确定LNR。分析了临床病理因素,MNV和LNR与无病生存期(DFS)和总生存期(OS)的关系。结果:五年DFS和OS分别为68.4和70.8%,中位随访49个月。在多变量分析中,MNV(> 30 ml)是DFS和OS的独立预后因素(分别为p = 0.004和p <0.001)。 LNR(> 0.14)被确定为DFS的独立预测因素(p = 0.041)。结论:MNV和LNR是CUP患者的独立预后因素,可以帮助识别需要加强治疗和监测的高危患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号